Ganoderma lucidum spore oil ameliorates high‐fat‐diet‐induced hepatic lipid metabolism disorder by modulation of the gut microbiota

BACKGROUND: Obesity is a major global public health challenge. A high-fat diet (HFD) is a key contributing factor, closely associated with gut microbiota dysbiosis. Although immunomodulatory effects of Ganoderma lucidum spore oil (GLSO) have been reported, its role in lipid metabolism disorders and its interaction with gut microbiota remain incompletely understood. RESULTS: ) for 82 days. Integrated analyses - including 16S rRNA sequencing, metabolomics, fecal fermentation of GLSO (FGLSO), and HepG2 cell experiments - were performed to evaluate metabolic effects and potential microbiota-related mechanisms. Ganoderma lucidum spore oil significantly reduced body weight gain, fasting blood glucose, serum lipid levels - including total cholesterol (TC), triglycerides (TG), and low-density lipoprotein cholesterol (LDL-C) - and inflammatory markers, specifically tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β) and interleukin-6 (IL-6). It also improved gut microbiota composition by increasing microbial diversity and enriching beneficial taxa such as Bacillus and unclassified_Muribaculaceae. These changes were accompanied by increased levels of short-chain fatty acids (SCFAs), particularly acetate and propionate, as well as alterations in bile acid metabolism. Further analysis suggested that metabolites may be associated with the regulation of hepatic lipid metabolism, potentially involving the peroxisome proliferator-activated receptor alpha (PPARα) signaling pathway. Fecal fermentation of GLSO exhibited stronger lipid-lowering effects than native GLSO in vitro, indicating that gut microbiota-mediated biotransformation may enhance the bioactivity of GLSO. CONCLUSION: Collectively, these findings suggest that GLSO alleviates HFD-induced metabolic disorders and highlight a potential role of gut microbiota in modulating its metabolic effects and enhancing its bioactivity. © 2026 Society of Chemical Industry.

Authors

Institutions

Publication Details

Journal
Journal of the Science of Food and Agriculture
Published
2026-09-16
DOI
https://doi.org/10.1002/jsfa.71035
Primary Topic
Gut microbiota and health
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Ganoderma lucidum spore oil ameliorates high‐fat‐diet‐induced hepatic lipid metabolism disorder by modulation of the gut microbiota

Xu Hui, Xinyi Zhou, Wenjian Yang, Minhao Xie et al.
Journal of the Science of Food and Agriculture
Gut microbiota and health
article

Ganoderma lucidum spore oil ameliorates high‐fat‐diet‐induced hepatic lipid metabolism disorder by modulation of the gut microbiota

Xu Hui, Xinyi Zhou, Wenjian Yang, Minhao Xie, Qian Yang, Jianhui Liu, Xinhui Wang, Yuanlan Yang, Zhenwei Yuan, Xiaoxue Lu, Anxiang Su, Jianing Zhang
article en

Abstract

BACKGROUND: Obesity is a major global public health challenge. A high-fat diet (HFD) is a key contributing factor, closely associated with gut microbiota dysbiosis. Although immunomodulatory effects of Ganoderma lucidum spore oil (GLSO) have been reported, its role in lipid metabolism disorders and its interaction with gut microbiota remain incompletely understood. RESULTS: ) for 82 days. Integrated analyses - including 16S rRNA sequencing, metabolomics, fecal fermentation of GLSO (FGLSO), and HepG2 cell experiments - were performed to evaluate metabolic effects and potential microbiota-related mechanisms. Ganoderma lucidum spore oil significantly reduced body weight gain, fasting blood glucose, serum lipid levels - including total cholesterol (TC), triglycerides (TG), and low-density lipoprotein cholesterol (LDL-C) - and inflammatory markers, specifically tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β) and interleukin-6 (IL-6). It also improved gut microbiota composition by increasing microbial diversity and enriching beneficial taxa such as Bacillus and unclassified_Muribaculaceae. These changes were accompanied by increased levels of short-chain fatty acids (SCFAs), particularly acetate and propionate, as well as alterations in bile acid metabolism. Further analysis suggested that metabolites may be associated with the regulation of hepatic lipid metabolism, potentially involving the peroxisome proliferator-activated receptor alpha (PPARα) signaling pathway. Fecal fermentation of GLSO exhibited stronger lipid-lowering effects than native GLSO in vitro, indicating that gut microbiota-mediated biotransformation may enhance the bioactivity of GLSO. CONCLUSION: Collectively, these findings suggest that GLSO alleviates HFD-induced metabolic disorders and highlight a potential role of gut microbiota in modulating its metabolic effects and enhancing its bioactivity. © 2026 Society of Chemical Industry.

Journal of the Science of Food and Agriculture
Nanjing University of Finance and Economics (CN), China Pharmaceutical University (CN)
National Natural Science Foundation of China
Good health and well-being
Openalex Percentile: Top 18%
Gut microbiota and health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.